Pfizer might consider GSK as “plan B”, analysts suggest

Add to My Stories Print page Add to Favourites

Analysts at Berenberg Bank have suggested that a potential move by pharmaceutical giant Pfizer for the UK’s GlaxoSmithKline might be “not totally unrealistic” after its failed attempt earlier in the…